Skip to Main Content
Illness, In the News

Evusheld & Paxlovid Available In-Clinic

March 01, 2022

COVID antibody and prophylactic prescriptions play an important role in curbing the ongoing pandemic, but they can also be hard to find. Not anymore. Paxlovid, an antiviral prescription medication, and Evusheld, a prophylactic medication for high risk individuals are now available at Innovative Care. If our medical provider recommends Paxlovid or Evusheld for your use, you will get your prescription AND the medication immediately on-site at our clinic. 

What is Paxlovid? 

Paxlovid is available by prescription only for patients age 12 and older. Paxlovid should be taken as soon as possible after diagnosis of COVID-19, and within five days of symptom onset. Review the FDA patient fact sheet for more information about this FDA EUA approved oral medication for the treatment of mild to moderate COVID-19. 

What is Evusheld? 

Evusheld is an investigational medicine used for the most vulnerable patient populations to be used before COVID exposure. Evusheld is designed to prevent infection. It is not a treatment for COVID. Two categories of patients qualify for Evusheld:

  1. Those who have a moderately to severely compromised immune system due to a medical condition, or due to taking immunosuppressive medications or treatments, who therefore may not mount an adequate immune response to COVID-19 vaccination. Qualifying medical conditions include, but are not limited to, the following:
    • Active treatment for solid tumor and hematologic malignancies
    • Receipt of solid-organ transplant and taking immunosuppressive therapy
    • Receipt of chimeric antigen receptor (CAR)-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
    • Moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
    • Advanced or untreated HIV infection 
    • Active treatment with high-dose corticosteroids (i.e., ≥20 mg prednisone or equivalent per day when administered for ≥2 weeks), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers, and other biologic agents that are immunosuppressive or immunomodulatory (e.g., B-cell depleting agents)
  2. Those who have a history of severe adverse reactions to a COVID-19 vaccine and/or components of those vaccines, and are therefore not eligible (or advised against getting) for the COVID vaccine

Evusheld is not an alternative to vaccine for the average person. It is an additional tool in our arsenal to fight COVID that is designed for a specific patient population. More information can be found in this patient fact sheet. If you believe you qualify for Evusheld, schedule an appointment for a provider evaluation.

Sotrovimab Monoclonal Antibody Treatment

Innovative Care also offers Sotrovimab Monoclonal antibodies, which serve as substitute antibodies that help our immune systems mimic the defense of natural COVID-19 antibodies. Sotrovimab is FDA EUA approved for the treatment of COVID-19.  Review the FDA patient fact sheet for more information. 

Schedule an Appointment

If you are diagnosed with COVID-19, schedule an appointment for COVID treatment online. 

If you have a moderately to severely compromised immune system and qualify for Evusheld, schedule an evaluation with one of our medical providers.

Background Image

Access the care you deserve.

Book your appointment today to experience what everyday healthcare should be.

Book My Appointment